Sven Almer - Publications

Relationships and Sexuality in Patients with Inflammatory Bowel Disease: Experiences of Patients and Healthcare Providers in Sweden.

Journal: Journal of clinical medicine

Published: September 15, 2025

Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).

Journal: BMJ open

Published: May 06, 2025

Classification of Paediatric Celiac Disease Using RNA Sequencing and Real-Time PCR of Duodenal Biomarkers.

Journal: Journal of cellular and molecular medicine

Published: April 22, 2025

Long-term real-world data of ustekinumab in ulcerative colitis: the Stockholm Ustekinumab Study (STOCUSTE).

Journal: European journal of gastroenterology & hepatology

Published: September 26, 2024

Health-related quality of life for patients with inflammatory bowel disease requires more than anti-inflammatory treatment

Journal: Lakartidningen

Published: August 14, 2024

Response to azathioprine treatment in autoimmune hepatitis is dependent on glutathione transferase genotypes.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 25, 2024

Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases.

Journal: Oral diseases

Published: December 10, 2023

Discerning Endoscopic Severity of Inflammatory Bowel Disease by Scoping the Peripheral Blood Transcriptome.

Journal: Gastro hep advances

Published: October 19, 2023

Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study.

Journal: Therapeutic advances in gastroenterology

Published: August 19, 2023

Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes.

Journal: Journal of Crohn's & colitis

Published: May 17, 2023

Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders.

Journal: International journal of molecular sciences

Published: December 13, 2022

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.

Journal: Therapeutic advances in gastroenterology

Published: December 12, 2022